Are you Dr. Leiden?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 56 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
Abbott Laboratories
100 Abbott Park Road
Abbott Park, IL 60064Phone+1 847-938-9313
Summary
- Dr. Jeffrey Leiden, MD is a cardiologist in Abbott Park, Illinois. He is currently licensed to practice medicine in Illinois and Massachusetts.
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1984 - 1985- Brigham and Women's HospitalResidency, Internal Medicine, 1981 - 1984
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1981
Certifications & Licensure
MA State Medical License 1983 - 2025
IL State Medical License 1992 - 2017
Awards, Honors, & Recognition
- Elected Member Institute of Medicine, 2001
- Investigator Alumnus Howard Hughes Medical Institute, 1987
Publications & Presentations
PubMed
- 78 citationsLong-Term Erythropoietin Expression in Rodents and Non-Human Primates Following Intramuscular Injection of a Replication-Defective Adenoviral VectorEric C. Svensson, Hugh B. Black, Debra L. Dugger, Sandeep K. Tripathy, Eugene Goldwasser
Human Gene Therapy. 1997-10-10 - 266 citationsExpression of recombinant genes in myocardium in vivo after direct injection of DNA.H Lin, M S Parmacek, G Morle, Steven F. Bolling, Jeffrey M. Leiden
Circulation. 1990-12-01 - 814 citationsGATA4 transcription factor is required for ventral morphogenesis and heart tube formation.Chay T. Kuo, Edward E. Morrisey, Roshani T. Anandappa, Kirsten Sigrist, Min M. Lu
Genes & Development. 1997-04-15
Press Mentions
Will the Workplace Ever Look the Same? MassMutal, UMass Amherst and TJX Share Their COVID Protocols for Employees Going ForwardAugust 14th, 2021- FDA Warns Acceleron of Possible Fines for Not Posting Results from Failed TrialApril 28th, 2021
- Vertex Pays $900M Upfront to Lead CTX001 Development with CRISPR TherapeuticsApril 20th, 2021
- Join now to see all
